Meridia May Do More Harm than Good
FDA Decides on Fate of Controversial Diet Pill This Month, Study Calls for It to Be Pulled from Market (Source: Health News: CBSNews.com)
Obesity Drug Pulled From U.S. Market
Abbott Laboratories, maker of Meridia (sibutramine), agreed to voluntarily withdraw the obesity drug
from the market because it might place users at increased risk of heart attack and stroke, according to an Oct. 8
announcement from the U.S. Food and Drug Administration. (Source: Modern Medicine)